Erste Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Erste Asset Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.97M	Hold	23,130	–	–	0.02%	340
2026 Q1	$2.96M	Hold	23,130	–	–	0.03%	319
2025 Q4	$2.82M	Buy	23,130 +22,130	+2,213%	+$2.54M	0.02%	322
2025 Q3	$100K	Buy	+1,000	New	+$90.1K	﹤0.01%	582

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Erste Asset Management's XBI Position: Q2 2026 in Review

Erste Asset Management held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 23,130 shares worth $2.97M. The position accounts for 0.02% of the portfolio, ranked #340.

Erste Asset Management first reported a position in XBI in Q3 2025 and has held it in 4 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Erste Asset Management held 23,130 shares of State Street SPDR S&P Biotech ETF worth $2.97M as of Q2 2026.
Erste Asset Management left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.02% of Erste Asset Management's portfolio in Q2 2026, its #340 holding.
Erste Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2025 and has held it in 4 quarters since.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.